McHugh T D, Bathgate T, Mangan J, Johnson J D, Holliman R E, Butcher P D
Department of Medical Microbiology, Royal Free Hospital School of Medicine, London.
J Med Microbiol. 1997 Jul;46(7):587-95. doi: 10.1099/00222615-46-7-587.
Current serological tests do not discriminate between asymptomatic latent Toxoplasma gondii infection and reactivating toxoplasmosis, but timely therapeutic intervention before the development of symptoms would lead to major reductions in morbidity and permanent disability. This study developed a new enzyme-linked immunosorbent assay (ELISA) for antibody to T. gondii tissue cyst antigens and screened tissue cyst antigens by Western blot analysis to test the hypothesis that antibody recognition of T. gondii tissue cyst-derived antigen is a good indicator of reactivation disease. A total of 187 sera was tested by Sabin-Feldman dye test and tissue cyst ELISA, AIDS patients and patients with ocular disease were considered separately, as the exposure to parasite antigens may be different in these two groups. The dye test did not discriminate between immunocompetent and immunocompromised T. gondii seropositive patients or between active and quiescent toxoplasmosis. Tissue cyst ELISA demonstrated a raised specific antibody response in immunocompetent T. gondii seropositive patients and in quiescent HIV positive sera. These data support th view that the tissue cyst population is in a state of dynamic equilibrium. It is proposed that, in the immunocompetent host, tissue cyst development and rupture are under some degree of immune control, but that in the immunocompromised host this equilibrium is disturbed and reactivation disease results. Data from patients with reactivating ocular toxoplasmosis demonstrate that tissue cyst-specific antibody levels are not different in active and quiescent disease and indeed they are not significantly different from immunocompetent T. gondii seronegative sera. In the Western blot analysis of 57 HIV positive patient sera, eight antigens (65, 57, 49, 47, 36, 28, 26 and 18 kDa) were consistently recognised by one third or more of the sera tested, but no single antigen was diagnostic of quiescent or active toxoplasmosis. It is concluded that tissue cyst-derived antigens are not a reliable serological marker of reactivating toxoplasmosis.
目前的血清学检测无法区分无症状的潜伏性弓形虫感染和再激活型弓形虫病,但在症状出现前及时进行治疗干预将大幅降低发病率和永久性残疾率。本研究开发了一种针对弓形虫组织囊肿抗原抗体的新型酶联免疫吸附测定(ELISA),并通过蛋白质印迹分析筛选组织囊肿抗原,以检验以下假设:对弓形虫组织囊肿衍生抗原的抗体识别是再激活疾病的良好指标。通过Sabin-Feldman染色试验和组织囊肿ELISA对总共187份血清进行了检测,艾滋病患者和眼部疾病患者被分别考虑,因为这两组人群对寄生虫抗原的暴露情况可能不同。染色试验无法区分免疫功能正常和免疫功能低下的弓形虫血清阳性患者,也无法区分活动性和静止性弓形虫病。组织囊肿ELISA显示,免疫功能正常的弓形虫血清阳性患者以及静止期HIV阳性血清中存在特异性抗体反应升高。这些数据支持组织囊肿群体处于动态平衡状态的观点。有人提出,在免疫功能正常的宿主中,组织囊肿的发育和破裂受到一定程度的免疫控制,但在免疫功能低下的宿主中,这种平衡被打破,导致再激活疾病。再激活型眼部弓形虫病患者的数据表明,活动性和静止性疾病中组织囊肿特异性抗体水平并无差异,实际上与免疫功能正常的弓形虫血清阴性血清也无显著差异。在对57份HIV阳性患者血清进行的蛋白质印迹分析中,八种抗原(65、57、49、47、36、28、26和18 kDa)被三分之一或更多检测血清一致识别,但没有单一抗原可诊断静止性或活动性弓形虫病。得出的结论是,组织囊肿衍生抗原不是再激活型弓形虫病的可靠血清学标志物。